Full Record Display for the EPA National Library Catalog

RECORD NUMBER: 106 OF 378

Main Title Development document for final effluent limitations guidelines, new source performance standards, and pretreatment standards for the pharmaceutical manufacturing point source category.
Author Hund, F. H.
CORP Author Environmental Protection Agency, Washington, DC. Effluent Guidelines Div.
Publisher U.S. Environmental Protection Agency, Office of Water, Effluent Guidelines Division,
Year Published 1983
Report Number EPA 440/1-83/084
Stock Number PB84-180066
OCLC Number 16959286
Subjects Drug factories--Effluent guidelines ; Drug factories--Environmental aspects ; Effluent quality ; Water--Pollution
Additional Subjects Water pollution control ; Drug industry ; Regulations ; Guidelines ; Standards ; Sources ; Industrial waste treatment ; Technology ; Cost analysis ; Design criteria ; Technology ; National government ; Pretreatment(Water) ; Water pollution abatement ; Point sources ; Best technology ; New source performance standards
Internet Access
Description Access URL
https://nepis.epa.gov/Exe/ZyPDF.cgi?Dockey=000014OZ.PDF
Holdings
Library Call Number Additional Info Location Last
Modified
Checkout
Status
EJAD  EPA 440/1-83-084 Region 3 Library/Philadelphia, PA 09/15/1995
EJBD  EPA 440-1-83-084 Headquarters Library/Washington,DC 10/06/2015
ELBD ARCHIVE EPA 440-1-83-084 Received from HQ AWBERC Library/Cincinnati,OH 10/04/2023
ESAD  EPA 440-1-83-084 Region 10 Library/Seattle,WA 11/08/2017
NTIS  PB84-180066 Some EPA libraries have a fiche copy filed under the call number shown. 07/26/2022
Collation 1 volume (various pagings) : illustrations
Abstract This document presents the findings of a study of the Pharmaceutical Manufacturing Point Source Category for the purpose of finalizing effluent limitations guidelines for existing and new point sources and to establish pretreatment standards for existing and new dischargers to publicly owned treatment works to implement Sections 301, 303, 306, 307, 308 and 501 of the Clean Water Act. The information presented supports final regulations based on best practicable control technology currently available (BPT) and best available technology (BAT), new source performance standards (NSPS) and pretreatment standards for new and existing sources (CPSNS) and (PSES) for the Pharmaceutical Manufacturing Point Source Category. The report presents and discusses data gathering efforts, consideration of subcategorization, characterization of wastewaters, selection of pollutant parameters, review of treatment technology, cost and non-water quality considerations and development of regulatory options and effluent limitations.
Notes "September 1983." Includes bibliographical references. Includes glossary.
Place Published Washington, D.C.
Access Notes Also available on the Internet. Viewed: April 10, 2008.
Corporate Au Added Ent United States. Environmental Protection Agency. Effluent Guidelines Division.
Alternate Title Pharmaceutical manufacturing point source category
PUB Date Free Form 1983
Ti Tra Differently Pharmaceutical manufacturing point source category.
NTIS Prices PC A12/MF A01
BIB Level m
Medium unmediated
Content text
Carrier volume
Cataloging Source OCLC/T
OCLC Time Stamp 20171031052700
Language eng
Origin OCLC
Type MERGE
OCLC Rec Leader 01460cam 2200373Ka 45010